RELIEF: The Changing Landscape of Axial Spondyloarthritis: Current and Emerging Agents for Individualized Treatment

WEDNESDAY, April 15, 2020

5:00 – 6:30 PM PT

08:00 PM Eastern; 07:00 PM Central; 06:00 PM Mountain; 05:00 PM Pacific

Activity Description

This case-based live activity will cover the treatment and management of patients with axial spondyloarthritis.

Target Audience

This activity is intended for rheumatologists and other healthcare professionals involved in the management of patients with axial spondyloarthritis.


Educational Objectives

Upon the completion of this program, attendees should be able to:

  • Examine the specific domains of axial spondyloarthritis (AxSpA) and their relationship to quality of life
  • Review current and emerging therapies used for AxSpA
  • Evaluate the IL-17/23 axis and its relationship to the pathophysiology of AxSpA
  • Compare outcomes measures used in clinical trials versus those that may be more practical for use in clinical practice

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturers of any commercial products and/or providers of commercial services that are discussed in an educational activity.

Disclosure of Conflicts of Interest

Neal S. Birnbaum, MD has received consulting fees from AbbVie and served on speakers’ bureaus for AbbVie, Amgen, Pfizer, and Sanofi/Regeneron.

Leonard H. Calabrese, DO, has received consulting fees from AbbVie, Genentech, Gilead, Horizon, Janssen, Lilly, Novartis, and Pfizer, and has served on speaker’s bureaus for AbbVie, Genentech, Horizon, Janssen, Lilly, and Novartis.

Planners and Managers

CME CONTENT REVIEW
The content of this activity was independently peer-reviewed.
The reviewer of this activity has nothing to disclose.

CNE CONTENT REVIEW
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

STAFF PLANNERS AND MANAGERS
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group has nothing to disclose.
Ashley Whitehurst, Program Manager of Med Learning Group has nothing to disclose.
Chris Drury, Medical Director of Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group has nothing to disclose.
Brianna Hanson, Accreditation and Outcomes Coordinator of Med Learning Group has nothing to disclose.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with axial spondyloarthritis. CNE Credits: 1.5 ANCC Contact Hours.

CNE Accreditation Statement: Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.5 contact hours of continuing nursing education of RNs and APNs.

Media

Internet

Disclosure of Unlabeled Use

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, faculty may mention the use of medications for both FDA-approved and non-approved indications.

Disclaimer

Med Learning Group makes every effort to develop CME activities that are science based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

Method of Participation and Request for Credit

There are no fees for participating and receiving CME credit for this live activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the live activity.
  3. Submit the evaluation form to Med Learning Group.

You will receive your certificate within 60 days of evaluation submission.

Contact Information for Questions About the Activity

AWhitehurst@medlearninggroup.com

System Requirements

Performedia requires a modern web browser (Microsoft Edge, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software.

Release date: April 15, 2020
Expiration date: April 15, 2020
Estimated time to completion: 1.5 hours